If someone amongst us has attended the recent AGM,I request that person to share the notes.
Posts tagged All News
Laurus Labs – Can Business Transform to Next Level? (02-11-2024)
7dc7fcbb-ed78-4011-ae2a-91d6eae6891c.pdf (558.3 KB)
Highlights from the recent con call and my findings:
- Revenue New revenue streams Animal health and Crop Science in coming years 2-3. Formulation segment (good margins) is also expected to contribute.
- Margin expectations in the coming quarters Management gave a guidance for 20% EBITDA margin for the full year for the current FY. The first half had a margin of 14-15% so one should expect a margin of 23-25% in the next two quarters which can go on for the next few financial years.
- This anticipated improvement is attributed to a strong order book and scheduled deliveries, particularly within the CDMO segment.
- This year growth is driven by the CDMO segment
- CDMO division is expected to drive the majority of the growth in FY25, the management anticipates growth across all segments, including Generic API and FDF in the coming years Q4 call will give a much better picture
- Operating deleverage the company is going through a deleverage phase due to the cap ex in the growth initiatives along with the challenges in the generic API segment
- Operating deleverage ends the management mentioned that the deleverage may have ended and we can expect the leverage to come into play after one or two quarters
- Cap ex plan of 2000 cr: Majorly of which will be in the CDMO, around 200 cr in Formulation segment, api will receive the lowest share.
- Growth triggers: Continued CDMO Growth (already doing well and good quarters expected), New Revenue Streams from Animal Health and Crop Sciences (in 2-3 years), Generic API Growth Through Portfolio Expansion (Currently struggling and going through deleverage because of the expansion but deleverage has ended as per management and leverage can kick in after few quarters which can improve margins), Formulations Business Expansion (good margin business can move up in the value chain)
Next 2-3 years outlook is good as of now with good capital appreciation as per me.
Disclaimer: Invested. Not a recommendation.
James Ledbetter, Media Critic and Business Journalist, Dies at 60 (02-11-2024)
He wrote the Press Clips column for The Village Voice, held top jobs at Inc. magazine and Slate, and wrote a book about how the startup magazine The Industry Standard fizzled.
The SME portfolio (02-11-2024)
@Dhvanit_Merchant17 Are you still tracking Cosmic CRF and Sunita tools? What is your opinion on them?
Tips Industries Limited – Ready to RACE ahead! (02-11-2024)
I went through the recent concall to make sense of the valuations, lately this had become more like a passive investment.
The stock trades at 75 p/e now. There are several brokerage reports covering the stock like Arihant capital etc. The DII and FII % are approaching 5%. Management as always have promised 30% growth and maybe only now the market has started believing. I am not an expert on valuations but 75 p/e for 30% growth looks expensive to me.
Concall wise, quite bullish.
Content acquisition is still going slow.
But their warner deal would provide a step up in grwth for the next 3-4 quarters. Warner was still ingesting content.
They are trying for brand sync deals. Signed one with motorola. Value not mentioned, more to come. No idea on how meaty this could be.
Yet to decide on events business, maybe next quarter there may be an update
Wynk app shutdown may impact for 15 days, management thinks users will move to other platforms
Deep Industries (DIL) (02-11-2024)
Management has said in recent concall, that they will book INR 100 crores every year from this order.
Paragon Fine and Speciality Chemical (02-11-2024)
They supply electronics pigment to a US based company. They have 4 produts – 2 are in market and 2 in r&d stage…
Planning 15-20% contribution from electronics segment over next few years.
NPST – Technology Provider for UPI Tech (02-11-2024)
After the earnings call and all the updates the company is doing great in a sense. But is this PE justified.
For a small cap even is the PE of 200 how is this justified.
What is the future growth after this if am buying this stock now even for 2-3 years.
What is the price appreciation that will take place, or will it consolidate for the earnings to catch up. The company is great and all but just the valuation and timing to enter a company is not as good in my view. I mean 200 PE, where is the PE going to go after this point
To view this in StockEdge, click StockEdge – Analyse Stocks in Indian Markets NSE and BSE
Multi-themed Long Term Portfolio (02-11-2024)
In the past few weeks, I have narrowed down my portfolio heavily on the Green Energy Transition Theme, apart from few name which I think can be emerging winners in some basic sectors. My basket looks like this now:
Green Energy Theme discussed here as well:
Which Stocks Will Benefit From India’s Green Energy Push? | Talking Point With Niraj Shah
Aeroflex Industries (02-11-2024)
Starting this thread to discuss aeroflex industries with all of you. Is anyone invested in this firm.
This company is of 2500Cr market cap right now.